This section is dedicated to the media, and it collects press releases on Gianni Bonadonna Foundation’s activities.

Press Release, September 14th 2022
Phost’In Therapeutics in collaboration with Fondazione Gianni Bonadonna, announces the dosing of the first three patients in the Dose Escalation phase of the PhAST trial, a Phase I study in patients with advanced solid tumors

Press Release, June 7th 2022
Phost’In Therapeutics announces approval of French and Italian Health Agencies for a first European clinical trial application in patients with advanced solid tumors, in collaboration with Fondazione Gianni Bonadonna: PhAST Trial

Press Release, February 11th 2022
To mark the International Day of Women in Science, Fondazione Gianni Bonadonna, with Prada Group as supporting partner, and Fondazione AIRC are happy to announce the winners of the first edition of the Call for proposals “Gianni Bonadonna” Fellowships

Press Release, April 21th 2021
Gianni Bonadonna Foundation – with Prada Group as supporting partner – and Fondazione AIRC announce the call for applications for the international fellowships in honor of Gianni Bonadonna”

Press Release, October 11th 2018
Prada Group and Gianni Bonadonna Foundation working together on an innovative cancer treatment and research project”